ArticlemBio2018
Erratum for Mor et al., "Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids".
Open access · goldAbstract readPublished Erratum
In one paragraph
Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 9 citations in OpenAlex.
- Design, synthesis and SAR studies of N'-(Ethynylsalicylidene)arenecarbohydrazides as next-generation broad-spectrum antifungal agents.Bioorganic & medicinal chemistry · 2025Article
- Targeting fungal lipid synthesis for antifungal drug development and potentiation of contemporary antifungals.npj antimicrobials and resistance · 2025Review
- SAR study of N'-(Salicylidene)heteroarenecarbohydrazides as promising antifungal agents.Bioorganic & medicinal chemistry · 2024Article
- The Future of Antifungal Drug Therapy: Novel Compounds and Targets.Antimicrobial agents and chemotherapy · 2021Review
- Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans andAntimicrobial agents and chemotherapy · 2020Article
- SAR Studies on Aromatic Acylhydrazone-Based Inhibitors of Fungal Sphingolipid Synthesis as Next-Generation Antifungal Agents.Journal of medicinal chemistry · 2019Article
- Glycosphingolipids and Infection. Potential New Therapeutic Avenues.Frontiers in cell and developmental biology · 2019Review
- Recent progress in the strategic incorporation of fluorine into medicinally active compounds.Journal of fluorine chemistry · 2019Article
Corrections and comments
- Erratum for
Authors and funding
35 authors at 9 institutions in 3 countries.
Visesato MorDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, USA.
Antonella RellaDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, USA.
Amir M FarnoudDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, USA.
Ashutosh SinghDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, USA.
Mansa MunshiDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, USA.
Arielle BryanDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, USA.
Shamoon NaseemDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, USA.
James B KonopkaDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, USA.
Iwao OjimaDepartment of Chemistry and Institute of Chemical Biology and Drug Discovery, Stony Brook University, Stony Brook, New York, USA.
Erika BullesbachDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina, USA.
Alan AshbaughDepartment of Veterans Affairs Medical Center, Cincinnati, Ohio, USA.
Michael J LinkeDepartment of Veterans Affairs Medical Center, Cincinnati, Ohio, USA.
Melanie CushionDepartment of Veterans Affairs Medical Center, Cincinnati, Ohio, USA.
Margaret CollinsUniversity of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Hari Krishna AnanthulaDepartment of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, Ohio, USA.
Larry SallansDepartment of Chemistry, University of Cincinnati, Cincinnati, Ohio, USA.
Pankaj B DesaiDepartment of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, Ohio, USA.
Nathan P WiederholdDepartment of Pathology, Fungus Testing Laboratory, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Annette W FothergillDepartment of Pathology, Fungus Testing Laboratory, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
William R KirkpatrickDivision of Infectious Diseases, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Thomas PattersonDivision of Infectious Diseases, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Lai Hong WongDepartment of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Colombia, Canada.
Sunita SinhaDepartment of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Colombia, Canada.
Guri GiaeverDepartment of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Colombia, Canada.
Corey NislowDepartment of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Colombia, Canada.
Patrick FlahertyDepartment of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts, USA.
Xuewen PanDepartment of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, USA.
Gabriele Vargas CesarInstituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Patricia de Melo TavaresInstituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Susana FrasesLaboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Kildare MirandaInstituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Marcio L RodriguesInstituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Chiara LubertoDepartment of Physiology and Biophysics, Stony Brook University, Stony Brook, New York, USA.
Leonardo NimrichterInstituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Maurizio Del PoetaDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, USA maurizio.delpoeta@stonybrook.edu.
Stony Brook University · USUniversidade Federal do Rio de Janeiro · BRThe University of Texas Health Science Center at San Antonio · USUniversity of British Columbia · CAUniversity of Cincinnati · USUniversity of Cincinnati Medical Center · USBaylor College of Medicine · USMedical University of South Carolina · USWorcester Polytechnic Institute · US
Funding
New antifungals targeting the synthesis of fungal sphingolipidsR01AI116420 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI Maurizio Del Poeta · 2016 to 2026
$7.6MLipid-mediated fungal pathogenesisR01AI125770 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI DEL POETA, MAURIZIO · 2016 to 2025
$6.2MNIAID NIH HHS R01 AI116420NIAID NIH HHS R01 AI125770
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.